Department of Ophthalmology, NYU Grossman School of Medicine, New York, NY, United States.
Department of Ophthalmology, NYU Grossman School of Medicine, New York, NY, United States; Department of Pathology, NYU Grossman School of Medicine, New York, NY, United States.
Matrix Biol. 2023 Nov;123:48-58. doi: 10.1016/j.matbio.2023.10.001. Epub 2023 Oct 2.
In this review we highlight emerging immune regulatory functions of lumican, keratocan, fibromodulin, biglycan and decorin, which are members of the small leucine-rich proteoglycans (SLRP) of the extracellular matrix (ECM). These SLRPs have been studied extensively as collagen-fibril regulatory structural components of the skin, cornea, bone and cartilage in homeostasis. However, SLRPs released from a remodeling ECM, or synthesized by activated fibroblasts and immune cells contribute to an ECM-free pool in tissues and circulation, that may have a significant, but poorly understood foot print in inflammation and disease. Their molecular interactions and the signaling networks they influence also require investigations. Here we present studies on the leucine-rich repeat (LRR) motifs of SLRP core proteins, their evolutionary and functional relationships with other LRR pathogen recognition receptors, such as the toll-like receptors (TLRs) to bring some molecular clarity in the immune regulatory functions of SLRPs. We discuss molecular interactions of fragments and intact SLRPs, and how some of these interactions are likely modulated by glycosaminoglycan side chains. We integrate findings on molecular interactions of these SLRPs together with what is known about their presence in circulation and lymph nodes (LN), which are important sites of immune cell regulation. Recent bulk and single cell RNA sequencing studies have identified subsets of stromal reticular cells that express these SLRPs within LNs. An understanding of the cellular source, molecular interactions and signaling consequences will lead to a fundamental understanding of how SLRPs modulate immune responses, and to therapeutic tools based on these SLRPs in the future.
在这篇综述中,我们强调了小富含亮氨酸的蛋白聚糖(SLRP)家族成员——赖氨酰聚糖、角膜蛋白聚糖、纤维调节素、大软骨素蛋白聚糖和核心蛋白聚糖——的新兴免疫调节功能。这些 SLRPs 作为细胞外基质(ECM)中胶原蛋白纤维的调节结构成分,在皮肤、角膜、骨骼和软骨的稳态中已经得到了广泛的研究。然而,从重塑的 ECM 中释放的 SLRPs,或由激活的成纤维细胞和免疫细胞合成的 SLRPs,会在组织和循环中产生无 ECM 池,这可能在炎症和疾病中有重要但尚未被充分认识的影响。它们的分子相互作用和它们影响的信号网络也需要进一步研究。在这里,我们介绍了 SLRP 核心蛋白的富含亮氨酸重复(LRR)基序、它们与其他 LRR 病原体识别受体(如 Toll 样受体(TLRs))的进化和功能关系,以在 SLRP 的免疫调节功能方面提供一些分子上的明确性。我们讨论了 SLRP 片段和完整蛋白的分子相互作用,以及这些相互作用如何被糖胺聚糖侧链调节。我们整合了这些 SLRPs 的分子相互作用的发现,以及它们在循环和淋巴结(LN)中的存在情况,LN 是免疫细胞调节的重要部位。最近的批量和单细胞 RNA 测序研究已经确定了在 LN 中表达这些 SLRPs 的基质网状细胞亚群。对细胞来源、分子相互作用和信号后果的理解将导致对 SLRPs 如何调节免疫反应的基本理解,并为未来基于这些 SLRPs 的治疗工具奠定基础。